Access to every trial dataset is crucial

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7463.462-b (Published 19 August 2004) Cite this as: BMJ 2004;329:462
  1. Paul Abrams, professor of urology (paul_abrams@bui.ac.uk)
  1. Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB

    EDITOR—Herxheimer's pleas for access to industry's trial data1 reminded me that I wrote to the Department of Health two or three years ago, “demanding” that all clinical trials be published either in a journal or on a company website within two years of completion. I had a less than satisfactory response …

    View Full Text

    Sign in

    Log in through your institution